From the OTC markets to a national exchange
What an uplisting is
An uplisting moves a company whose shares trade on OTCQX, OTCQB, or Pink onto NASDAQ or NYSE — where index funds, institutional mandates, and margin eligibility open up, and where a listing carries the credibility the OTC markets cannot confer. The company keeps its reporting history and its shareholder base; what changes is the venue, and everything the venue makes possible.
The work, in order
- Gap analysis — the company today versus the exchange’s quantitative standards: price, float, round-lot holders, and the financial tests, plus governance composition.
- The campaign — closing each gap in order: audits, board and committee build-out, shareholder base development, and, where required, a reverse split or a concurrent offering to meet price and float standards.
- The application — the exchange application and the dialogue with listing qualifications staff, with the company’s OTC trading history presented properly.
- The switch — coordination of the ticker transition, DTC, and the first day of exchange trading.
Which path fits
Three questions decide it: does the company need new capital, who are its natural investors, and how fast must it be public? An existing OTC quote points to an uplisting; liquidity without capital needs points to a direct listing; and a broad public raise points to Regulation A+. The first deliverable of every engagement is exactly this analysis.
Discuss an uplisting mandate: contact the firm · info@directlylisted.com.